Steris (STE) Cash from Financing Activities (2018 - 2026)

Steris' (STE) quarterly Cash from Financing Activities came in at -$97.9 million in Q1 2026, up 45.03% year-on-year from -$67.5 million in Q1 2025, and little changed quarter-over-quarter from -$98.0 million in Q4 2025.

Steris (STE) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Steris' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$97.9 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 45.03% year-over-year to -$97.9 million in Q1 2026; TTM through Mar 2026 was -$568.2 million, a 63.86% increase from a year earlier, with the FY2026 full-year figure at -$568.2 million, up 63.86% from the prior year.
  • Cash from Financing Activities steadied at -$97.9 million in Q1 2026 per STE's latest filing, from -$98.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $470.2 million in Q3 2023 and bottomed at -$998.9 million in Q2 2024.
  • The 5-year median for Cash from Financing Activities is -$178.1 million (2025), against an average of -$176.4 million.
  • Across the five-year window, Cash from Financing Activities surged 1146.13% in 2023 and plunged 367.57% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$120.4 million in 2022, then slumped by 64.43% to -$198.0 million in 2023, then declined by 8.29% to -$214.4 million in 2024, then surged by 54.29% to -$98.0 million in 2025, then rose by 0.1% to -$97.9 million in 2026.
  • Per Business Quant, the three latest STE Cash from Financing Activities figures stand at -$97.9 million (Q1 2026), -$98.0 million (Q4 2025), and -$159.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -97.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -97.90 Mn
Mar 31, 2026 -97.90 Mn
Dec 31, 2025 -98.00 Mn
Dec 31, 2025 -98.00 Mn
Sep 30, 2025 -159.20 Mn
Sep 30, 2025 -159.20 Mn
Jun 30, 2025 -213.10 Mn
Jun 30, 2025 -213.10 Mn
Mar 31, 2025 -178.10 Mn
Mar 31, 2025 -178.10 Mn
Dec 31, 2024 -214.40 Mn
Dec 31, 2024 -214.40 Mn
Sep 30, 2024 -181.00 Mn
Sep 30, 2024 -181.00 Mn
Jun 30, 2024 -998.90 Mn
Jun 30, 2024 -998.90 Mn
Mar 31, 2024 -143.78 Mn
Mar 31, 2024 -143.78 Mn
Dec 31, 2023 -197.99 Mn
Dec 31, 2023 -197.99 Mn